According to a report by The Times of India on September 25th, the Council of Scientific and Industrial Research (CSIR) in India has developed a new variety of tobacco with nicotine content 40%-50% lower than regular tobacco, aimed at reducing the impact on public health.
According to N Kalaiselvi, the Director General of the Council of Scientific and Industrial Research (CSIR), India, a new variety of tobacco has been developed by a research institution under the guidance of Prime Minister Narendra Modi. This tobacco variant has a reduced nicotine content of 40%-50% compared to regular tobacco, aiming to minimize its impact on health. "Therefore, even if consumers use tobacco, its effects on health will be minimized as much as possible," stated Kalaiselvi.
Prime Minister Modi has previously proposed the possibility of developing such a type of tobacco, and the laboratory has successfully developed this new variety of tobacco to mitigate its effects on health. Karaseelvi stated that the laboratory is continuing its efforts to further reduce its impact by 60% - 70%.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
